• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

管理填塞并发症经导管消融治疗心房颤动:与传统延迟拔除相比,早期拔除心包引流管安全有效,可减少镇痛需求和住院时间。

Management of Tamponade Complicating Catheter Ablation for Atrial Fibrillation: Early Removal of Pericardial Drains Is Safe and Effective and Reduces Analgesic Requirements and Hospital Stay Compared to Conventional Delayed Removal.

机构信息

Oxford University Hospitals NHS Foundation Trust, Department of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom.

Oxford University Hospitals NHS Foundation Trust, Department of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom.

出版信息

JACC Clin Electrophysiol. 2017 Apr;3(4):367-373. doi: 10.1016/j.jacep.2016.09.016. Epub 2016 Nov 30.

DOI:10.1016/j.jacep.2016.09.016
PMID:29759449
Abstract

OBJECTIVES

This study reports on the safety of early removal of pericardial drains after cardiac tamponade complicating atrial fibrillation catheter ablation (AFCA) procedures, the need for repeat pericardiocentesis, major adverse outcomes, as well as length of stay, and the need for opiate analgesia.

BACKGROUND

Tamponade from AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 h later) in case of re-bleeding. A drain in situ often causes severe pain but ongoing blood loss is rare. Our institution adopted the practice of early removal of drains before leaving the laboratory if bleeding has stopped.

METHODS

The authors performed a retrospective descriptive analysis of 43 cases of tamponade complicating AFCA from 2006 to 2015, comparing patients in whom the drain was removed early (group early removal [ER]; n = 25) versus traditional delayed removal (group delayed removal [DR]; n = 18).

RESULTS

The groups were similar with respect to clinical/demographic characteristics, proportions of first-time versus re-do and pulmonary vein isolation versus pulmonary vein isolation + additional ablation. There were no deaths. No ER patients required drain re-insertion before discharge. The length of stay was shorter in the ER group (3 days; range 1 to 9 days) than in the DR group (4 days; range 2 to 60 days). The requirement for opiate analgesia was less in the ER group (8%) than in the DR group (72%).

CONCLUSIONS

Early removal of pericardial drains after tamponade complicating AFCA procedures appears to be safe and effective, with re-insertion not required in this cohort. The traditional practice of leaving drains in situ for 12 to 24 h may result in more patient discomfort and longer hospitalization.

摘要

目的

本研究报告了心房颤动导管消融(AFCA)术后并发心脏压塞时早期拔除心包引流管的安全性,包括重复心包穿刺的需求、主要不良结局、住院时间以及阿片类镇痛药的需求。

背景

AFCA 引起的心包填塞传统上通过心包穿刺治疗,并在再次出血时延迟拔除引流管(通常在 12 至 24 小时后)。引流管原位常引起严重疼痛,但持续失血很少见。本机构采用的做法是,如果出血停止,在离开实验室前早期拔除引流管。

方法

作者对 2006 年至 2015 年期间 43 例 AFCA 并发心脏压塞的病例进行了回顾性描述性分析,比较了引流管早期拔除(早期拔除组 [ER],n=25)与传统延迟拔除(延迟拔除组 [DR],n=18)的患者。

结果

两组在临床/人口统计学特征、首次与再次、肺静脉隔离与肺静脉隔离+附加消融的比例方面相似。无死亡病例。无 ER 患者在出院前需要重新插入引流管。ER 组的住院时间较短(3 天;范围 1 至 9 天),而 DR 组(4 天;范围 2 至 60 天)较长。ER 组需要阿片类镇痛药的比例(8%)低于 DR 组(72%)。

结论

AFCA 术后并发心脏压塞时早期拔除心包引流管似乎是安全有效的,在本队列中无需再次插入。传统上留置引流管 12 至 24 小时的做法可能会导致更多的患者不适和更长的住院时间。

相似文献

1
Management of Tamponade Complicating Catheter Ablation for Atrial Fibrillation: Early Removal of Pericardial Drains Is Safe and Effective and Reduces Analgesic Requirements and Hospital Stay Compared to Conventional Delayed Removal.管理填塞并发症经导管消融治疗心房颤动:与传统延迟拔除相比,早期拔除心包引流管安全有效,可减少镇痛需求和住院时间。
JACC Clin Electrophysiol. 2017 Apr;3(4):367-373. doi: 10.1016/j.jacep.2016.09.016. Epub 2016 Nov 30.
2
Early versus delayed removal of the pericardial drain in patients with cardiac tamponade complicating radiofrequency ablation of atrial fibrillation.早期与延迟移除心包引流管在并发于心房颤动射频消融术的心包填塞患者中的应用。
J Cardiovasc Electrophysiol. 2020 Mar;31(3):597-603. doi: 10.1111/jce.14332. Epub 2020 Jan 10.
3
Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.因心房颤动导管消融术并发心脏压塞而接受心包穿刺术的患者的围手术期抗凝治疗。
Int Heart J. 2015;56(1):56-61. doi: 10.1536/ihj.14-158. Epub 2014 Dec 11.
4
[The timing of pericardial drainage catheter removal and restart of the anticoagulation in patients suffered from perioperative pericardial tamponade during atrial fibrillation catheter ablation and uninterrupted dabigatran: Experiences from 20 cases].[心房颤动导管消融术中围手术期心包填塞患者心包引流导管拔除时机及达比加群抗凝治疗重启:20例经验]
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Jan 24;51(1):45-50. doi: 10.3760/cma.j.cn112148-20220923-00743.
5
Two cases of delayed cardiac tamponade due to pericarditis after pulmonary vein (PV) isolation for atrial fibrillation.两例因心房颤动行肺静脉隔离术后心包炎导致的迟发性心脏压塞。
Intern Med. 2015;54(7):791-6. doi: 10.2169/internalmedicine.54.2537. Epub 2015 Apr 1.
6
Complications of transseptal catheterization for different cardiac procedures.不同心脏手术经房间隔穿刺导管的并发症。
Int J Cardiol. 2013 Oct 15;168(6):5352-4. doi: 10.1016/j.ijcard.2013.08.004. Epub 2013 Aug 14.
7
Management of cardiac tamponade in catheter ablation of atrial fibrillation: single-centre 15 year experience on 5222 procedures.心脏压塞在心房颤动导管消融中的管理:5222 例单中心 15 年经验。
Europace. 2018 Nov 1;20(11):1776-1782. doi: 10.1093/europace/eux307.
8
Pericardial drain removal following atrial fibrillation ablation: The longer we delay, the more we pay.心房颤动消融术后心包引流管拔除:拖延越久,代价越高。
J Cardiovasc Electrophysiol. 2020 Mar;31(3):604-606. doi: 10.1111/jce.14354. Epub 2020 Jan 24.
9
A strategy of idarucizumab for pericardial tamponade during perioperative period of atrial fibrillation ablation.心房颤动消融围手术期心包填塞时使用依达鲁珠单抗的策略。
Pacing Clin Electrophysiol. 2021 Nov;44(11):1824-1831. doi: 10.1111/pace.14344. Epub 2021 Sep 28.
10
Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin.华法林抗凝治疗期间心房颤动消融术中心脏压塞的处理和结局。
Heart Rhythm. 2011 Jun;8(6):805-8. doi: 10.1016/j.hrthm.2011.01.020. Epub 2011 Jan 12.

引用本文的文献

1
Epicardial ventricular arrhythmia ablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.心外膜室性心律失常消融:欧洲心脏病学会欧洲心律协会、心律协会、亚太心律协会、拉丁美洲心律协会及加拿大心律协会的临床共识声明
Europace. 2025 Mar 28;27(4). doi: 10.1093/europace/euaf055.
2
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024年欧洲心律协会/心律协会/亚太心律协会/拉丁美洲心律协会关于心房颤动导管消融和外科消融的专家共识声明
J Arrhythm. 2024 Oct 6;40(6):1217-1354. doi: 10.1002/joa3.13082. eCollection 2024 Dec.
3
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心律协会/心律学会/亚太心律学会/拉丁美洲心律学会专家共识声明:关于心房颤动的导管和手术消融。
J Interv Card Electrophysiol. 2024 Aug;67(5):921-1072. doi: 10.1007/s10840-024-01771-5.
4
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心脏节律协会/心律学会/亚太心脏节律学会/拉丁美洲心脏节律学会专家共识声明:导管和手术消融治疗心房颤动。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae043.
5
Advancements in Imaging for Atrial Fibrillation Ablation: Is There a Potential to Improve Procedural Outcomes?心房颤动消融成像技术的进展:是否有改善手术效果的潜力?
J Innov Card Rhythm Manag. 2020 Jul 15;11(7):4172-4178. doi: 10.19102/icrm.2020.110701. eCollection 2020 Jul.
6
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study.依达赛珠单抗用于达比加群抗凝作用的紧急逆转:一项日本上市后监测研究的中期结果
Cardiol Ther. 2020 Jun;9(1):167-188. doi: 10.1007/s40119-020-00165-8. Epub 2020 Mar 9.